Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization

Surgery (United States)

Volumn 162, Issue 1, 2017, Pages 37-47

  Cieslak, Kasia P ^a   Huisman, Floor ^a   Bais, Thomas ^a   Bennink, Roelof J ^a   van Lienden, Krijn P ^a   Verheij, Joanne ^a   Besselink, Marc G ^a   Busch, Olivier R C ^a   van Gulik, Thomas M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLIZATION; CONTROLLED STUDY; FEMALE; HEPATIC PORTAL VEIN; HEPATOBILIARY SCINTISCANNING; HUMAN; LIVER CANCER; LIVER FAILURE; LIVER FUNCTION; LIVER HYPERTROPHY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NEOADJUVANT CHEMOTHERAPY; PATIENT IDENTIFICATION; POSTOPERATIVE COMPLICATION; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; X-RAY COMPUTED TOMOGRAPHY; ADVERSE EFFECTS; DIAGNOSTIC IMAGING; HYPERTROPHY; LIVER NEOPLASMS; LIVER REGENERATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; SCINTISCANNING;

AGED; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; HYPERTROPHY; LIVER FAILURE; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; PATIENT SELECTION; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE IMAGING; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85016480936     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2016.12.031     Document Type: Article

References (34)

1. van Lienden, K.P., van den Esschert, J.W., de Graaf, W., Bipat, S., Lameris, J.S., van Gulik, T.M., et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 36 (2013), 25–34.
2. Wicherts, D.A., de Haas, R.J., Andreani, P., Sotirov, D., Salloum, C., Castaing, D., et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 97 (2010), 240–250.
3. de Graaf, W., Bennink, R.J., Vetelainen, R., van Gulik, T.M., Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation. J Nucl Med 51 (2010), 742–752.
4. Kinoshita, H., Sakai, K., Hirohashi, K., Igawa, S., Yamasaki, O., Kubo, S., Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10 (1986), 803–808.
5. Shindoh, J., Truty, M.J., Aloia, T.A., Curley, S.A., Zimmitti, G., Huang, S.Y., et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216 (2013), 201–209.
6. Huisman, F., Cieslak, K.P., van Lienden, K.P., Bennink, R.J., van Gulik, T.M., Liver related complications in unresectable disease after portal vein embolization. HBSN, 2017 in press.
7. de Graaf, W., van den Esschert, J.W., van Lienden, K.P., van Gulik, T.M., Induction of tumor growth after preoperative portal vein embolization: is it a real problem?. Ann Surg Oncol 16 (2009), 423–430.
8. May, B.J., Madoff, D.C., Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol 29 (2012), 81–89.
9. van Gulik, T.M., van den Esschert, J.W., de Graaf, W., van Lienden, K.P., Busch, O.R., Heger, M., et al. Controversies in the use of portal vein embolization. Dig Surg 25 (2008), 436–444.
10. Hoekstra, L.T., van Lienden, K.P., Doets, A., Busch, O.R., Gouma, D.J., van Gulik, T.M., Tumor progression after preoperative portal vein embolization. Ann Surg 256 (2012), 812–817.
11. Schnitzbauer, A.A., Lang, S.A., Goessmann, H., Nadalin, S., Baumgart, J., Farkas, S.A., et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255 (2012), 405–414.
12. Schadde, E., Ardiles, V., Slankamenac, K., Tschuor, C., Sergeant, G., Amacker, N., et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg, 2014, 1510–1519.
13. Beppu, T., Hayashi, H., Okabe, H., Masuda, T., Mima, K., Otao, R., et al. Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol 46 (2011), 938–943.
14. de Graaf, W., van Lienden, K.P., van den Esschert, J.W., Bennink, R.J., van Gulik, T.M., Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98 (2011), 825–834.
15. Hirai, I., Kimura, W., Fuse, A., Suto, K., Urayama, M., Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 133 (2003), 495–506.
16. Nanashima, A., Tobinaga, S., Abo, T., Sumida, Y., Araki, M., Hayashi, H., et al. Relationship of hepatic functional parameters with changes of functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization: a follow-up report. J Surg Res 164 (2010), e235–e242.
17. de Graaf, W., van Lienden, K.P., Dinant, S., Roelofs, J.J., Busch, O.R., Gouma, D.J., et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 14 (2010), 369–378.
18. Guglielmi, A., Ruzzenente, A., Conci, S., Valdegamberi, A., Iacono, C., How much remnant is enough in liver resection?. Dig Surg 29 (2012), 6–17.
19. Cieslak, K.P., Bennink, R.J., de Graaf, W., van Lienden, K.P., Besselink, M.G., Busch, O.R., et al. Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. HPB (Oxford) 18 (2016), 773–780.
20. Chapelle, T., Op De Beeck, B., Huyghe, I., Francque, S., Driessen, A., Roeyen, G., et al. Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?. HPB (Oxford) 18 (2016), 494–503.
21. Truant, S., Baillet, C., Deshorgue, A.C., Leteurtre, E., Hebbar, M., Ernst, O., et al. Drop of total liver function in the interstages of the new associating liver partition and portal vein ligation for staged hepatectomy technique: analysis of the “auxiliary liver” by HIDA scintigraphy. Ann Surg 263 (2016), e33–e34.
22. Bennink, R.J., Dinant, S., Erdogan, D., Heijnen, B.H., Straatsburg, I.H., van Vliet, A.K., et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med 45 (2004), 965–971.
23. Erdogan, D., Heijnen, B.H., Bennink, R.J., Kok, M., Dinant, S., Straatsburg, I.H., et al. Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test. Liver Int 24 (2004), 117–123.
24. Bennink, R.J., Tulchinsky, M., de Graaf, W., Kadry, Z., van Gulik, T.M., Liver function testing with nuclear medicine techniques is coming of age. Semin Nucl Med 42 (2012), 124–137.
25. Ekman, M., Fjalling, M., Friman, S., Carlson, S., Volkmann, R., Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nucl Med Commun 17 (1996), 235–242.
26. Mosteller, R.D., Simplified calculation of body-surface area. N Engl J Med, 317, 1987, 1098.
27. de Graaf, W., van Lienden, K.P., van Gulik, T.M., Bennink, R.J., (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med 51 (2010), 229–236.
28. de Baere, T., Teriitehau, C., Deschamps, F., Catherine, L., Rao, P., Hakime, A., et al. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17 (2010), 2081–2089.
29. Bednarsch, J., Jara, M., Lock, J.F., Malinowski, M., Pratschke, J., Stockmann, M., Noninvasive diagnosis of chemotherapy induced liver injury by LiMAx test - two case reports and a review of the literature. BMC Res Notes, 8, 2015, 99.
30. Giraudo, G., Greget, M., Oussoultzoglou, E., Rosso, E., Bachellier, P., Jaeck, D., Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 143 (2008), 476–482.
31. Malinowski, M., Stary, V., Lock, J.F., Schulz, A., Jara, M., Seehofer, D., et al. Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization. Langenbecks Arch Surg 400 (2015), 237–246.
32. van den Broek, M.A., Olde Damink, S.W., Dejong, C.H., Lang, H., Malagó, M., Jalan, R., et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28 (2008), 767–780.
33. Cieslak, K.P., Olthof, P.B., van Lienden, K.P., Besselink, M.G., Busch, O.R., van Gulik, T.M., et al. Assessment of liver function using 99mTc-mebrofenin hepatobiliary scintigraphy in ALPPS (associating liver partition and portal vein ligation for staged hepatectomy). Case Rep Gastroenterol 9 (2015), 353–360.
34. Leung, U., Simpson, A.L., Araujo, R.L., Gönen, M., McAuliffe, C., Miga, M.I., et al. Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg 219 (2014), 620–630.